KNOWLEDGE BANK

Interviews

Designing and Developing Green Drug Delivery Systems

Scientist, University of Kansas
Dr Sagar Salave is a Scientist at the University of Kansas USA specializing in mRNALNP therapeutics and viral vaccine formulation With a background in major pharmaceutical MNCs including Lupin and Ciron Drugs he possesses extensive expertise in drug discovery and nanotechnologydriven RD He serves as an Associate Editor for Applied Biochemistry and Biotechnology Journal Springer and sits on the Ed...

Articles

The Therapeutics Landscape of Miniproteins

marks years since the approval of the first monoclonal antibody mAb muromononabCD OKT in Over four decades the pharmaceutical industry has accumulated an extraordinary body of knowledge on how to discover engineer manufacture and safely administer antibodybased therapeutics

Research Insights

A Mathematical Framework for the Quantitative Analysis of Genetic Buffering

Genetic buffering plays a pivotal role in orchestrating the relationship between genotype and phenotype in outbred populations While highthroughput screens have identified many instances of genetic buffering

Case Studies

Case Study: A Simple And Sensitive Method To Analyze Genotoxic Impurityhydrazine In Pharmaceutical Materials

Abstract Hydrazine NH is a known genotoxic impurity that typically needs to be controlled down to low ppm level in pharmaceutical development Hydrazine however is a challenging molecule to analyze using conventional analytical techniques due to its physical and chemical properties eg lack of chromophore absence of any carbon atom low molecular weigh

Techno Trends

HUTCHMED Introduces First-of-its-Kind Savolitinib for Gastric Cancer Treatment

HUTCHMED has introduced firstofitskind savolitinib for the treatment of patients with locally advanced or metastatic gastric cancer or gastroesophageal junction GEJ adenocarcinoma patients with mesenchymal epithelial transition factor MET amplification who have failed to responded to at least two standard treatments

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Metabolic Stability

Rajesh Sonti

Rajesh Sonti is working as an Assistant Professor since Feb 2020 in Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad. He completed PhD from IISc, Bangalore and later worked as a post doc in University of Basel and EPFL-Lausanne for 6.5 years.

 

Venkata Rao Kaki

Venkata Rao Kaki is working as an Assistant Professor in Department of Chemical Sciences (medicinal chemistry/natural products),NIPER-Hyderabad. He completed PhD from Panjab university, Chandigarh. He has 4 years industrial and 8 years of academic experience.

 

Siva Nageswara Rao Gajula

Siva Nageswara Rao Gajulais pursuing PhD in Department of Pharmaceutical Analysis, NIPER-Hyderabad. He is working in the scientific areas:Drug Metabolism and Pharmacokinetics (DMPK), biomarkers and drug-drug interactions. He did M.S. (Pharm.) in department of pharmaceutical Analysisfrom NIPER-Ahmedabad.

 

Nadimpalli Nimisha

Pursued M.S. (Pharm.), National Institute of Pharmaceutical Education and Research (NIPER)

Megha Sajakumar Pillai

Megha Sajakumar Pillai pursued M.S. (Pharm.) in department of pharmaceutical Analysis, NIPER-Hyderabad. She is currently pursuing PhD in NIPER-Ahmedabad.

 

2

Syringe-like Bacterial Nanomachine Emerges as Potential Therapeutics Delivery Device

Chanchal Kumawat

I am Chanchal Kumawat. I started my journey in science as Ph.D. student at Regional Centre for Biotechnology and continued as postdoctoral fellow at Max Perutz labs, Austria.  I enjoyed making scientific discoveries in the laboratory and now, enjoy communicating it as a science writer.

 

3

Approach for Producing Pharmaceuticals in Layer By Layer Fashion: Additive Manufacturing

Lakshmi usha Ayalasomayajula

Lakshmi usha Ayalasomayajula is an Assistant Professor in the Department of Pharmaceutical Technology at M.R. College of Pharmacy, India with 9 years of teaching and research experience. She has published 30 papers in international and national journals and has presented 20 papers in various conferences as author and co-author.

 

Earle Radha Rani

Earle Radha Rani is working as assistant professor in department of pharmaceutical technology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has 7 years of teaching experience and has published over 30 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.

 

AVS Ksheera Bhavani

AVS Ksheera Bhavani is working as assistant professor in department of Pharmaceutical Biotechnology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has about 10 years of teaching experience and has published over 10 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.

 

Kishore Pathivada

kishore pathivada ,an under graduate from Maharajah's college of pharmacy, Vizianagaram, during the year, 2017-21. I Qualified GPAT-2021 with AIR 705 and I also got qualified in NIPER JEE-2021 with AIR 62.Currently Iam pursuing my master's degree in Dept. of pharmaceutical Analysis at NIPER Mohali, Punjab which is one of the top most reputed colleges in INDIA in the field of Pharmaceutical Sciences and Research.

 

4

The Growing Role of Biocatalysis in Industrial Synthesis

Dr Reuben Carr

Dr Reuben Carr has over 25 years of experience in developing proprietary biocatalytic processes for fine chemical and pharmaceutical manufacturing. He specialises in using directed evolution to engineer natural enzymes to carry out novel chemical reactions, enabling the synthesis of challenging molecular targets for clients and customers.

5

Precision medicine for Alzheimer’s Disease

Dr. Parmi Tripathi

Dr Parmi is a scientific researcher and an expert medical writer with Ph.D specialising in neurosciences. With an extensive pharmaceutical and healthcare industry experience, she excels at driving innovation. Focused at patient’s centricity, she has played key role in developing innovative medicines that makes meaningful impact on patient’s lives. Dr Parmi has made significant contribution at establishing a patented mouth-dissolving strip (MDS) manufacturing facility. With proven expertise in novel product development, her strong emphasis on quality manufacturing has led to structuring of quality documentation practices for this novel & patented MDS technology aligned with regulatory standards.

Dr Parmi has made significant contributions in field of neuroscience research with multiple acclaimed publications. A distinguished medical writer, she serves as editorial board member and peer reviewer in prestigious journals and continuous to make an impact in her field. Author at reputed public health platform, she writes to promote health awareness. Recognised for her exceptional contributions, she is a multiple-time government R&D grant recipient, particularly in neurodegenerative disorder studies.

press releasesRead more...

BIX 2026 Names Canada as Country of Honor Showcasing Bioindustry Trends from BCI To Biotech Foods

BIOPLUSINTERPHEX KOREA BIX Koreas largest biotechnology and pharmaceutical convention will be held at COEX in Seoul from October to Supported by the Ministry of Trade Industry and Resources this years BIX will feature over companies from around the world Canada will participate as the Country o...

Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.

Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform

Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership

Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed

UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases

Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong

EventsRead more...

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

30 - 01

Sep 2026

Pharma Launch Excellence Summit

Hyatt Regency Boston Harbor, B...

01 - 01

Oct 2026

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

LATEST NEWSRead more...

Turbine and Daiichi Sankyo Expand ADC Discovery Collaboration

Turbine and Daiichi Sankyo have expanded their collaboration to support antibodydrug conjugate ADC discovery using computational modelling

TriSalus Receives FDA Clearance for TriNav Advance for Liver Embolisation

TriSalus Life Sciences has received k clearance from the US Food and Drug Administration FDA for TriNav Advance a new device within its PressureEnabled Drug Delivery PEDD portfolio for liverdirected embolisation procedures

SK pharmteco and GEMMABio Expand Manufacturing Collaboration for SMA Gene Therapy

SK pharmteco and Gemma Biotherapeutics GEMMABio have expanded their manufacturing collaboration to support the clinical development of GB an investigational gene therapy for spinal muscular atrophy type SMA

Merck’s KEYTRUDA QLEX Approved for Subcutaneous Administration

Merck has announced that Japans Ministry of Health Labour and Welfare MHLW has approved KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfapmph for subcutaneous administration

Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases

Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases

Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease

Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD